ArticleFrontiers in endocrinology2025
Postprandial triglyceride-rich lipoproteins as predictors of carotid atherosclerosis in individuals with normal fasting lipid profiles: a prospective follow-up study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metrnl as a predictive biomarker for postprandial hypertriglyceridemia in overweight and obese populations.Frontiers in endocrinology · 2026Article
- Cardiovascular risk factors in fasting and postprandial lipid profiles among type 2 diabetes patients.Bioinformation · 2026Article
- From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health.Frontiers in cardiovascular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carotid atherosclerosis (CAS), a key precipitator of cardiovascular incidents, is linked to postprandial triglyceride-rich lipoproteins (TRL), as reflected by elevated triglycerides (TG) and remnant cholesterol (RC). This study explores the oral fat tolerance test (OFTT) for its predictive value in CAS, using postprandial TRL levels as a diagnostic biomarker. Methods: A total of 107 volunteers with normal fasting lipid profiles and no CAS at baseline were included. They received an OFTT after consuming a meal containing 60% fat (1500 kcal). Serum lipid profiles were monitored at fasting and 2, 4, 6, 8, and 10 h postprandially. The participants were categorized into postprandial normotriglyceridemia and postprandial hypertriglyceridemia groups based on their postprandial TG levels. After a 6-year follow-up, fasting lipid profiles and CAS status were reassessed. The baseline fasting and postprandial lipid levels in the CAS and non-CAS groups were compared. Repeated-measures analysis of variance was used to analyze the postprandial lipid profiles across different groups. Logistic regression models were constructed to assess the effects of postprandial TG and RC levels on CAS incidence. Results: The incidence of CAS in the postprandial hypertriglyceridemia group was 66.0%, which was significantly higher than the 13.3% observed in the postprandial normotriglyceridemia group ( Conclusion: The standardized OFTT has predictive value for CAS, and elevated TRL levels after a high-fat meal in individuals with normal fasting lipid profiles may serve as an early marker for CAS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.